Overview
Comparative Study of Ologen Collagen Matrix Versus Mitomycin-C in Trabeculectomy: A Study in Germany
Status:
Unknown status
Unknown status
Trial end date:
2011-11-01
2011-11-01
Target enrollment:
0
0
Participant gender:
All
All
Summary
The aim of this prospective randomized study is to investigate the efficacy and safety of trabeculectomy with ologen Collagen Matrix versus trabeculectomy using mitomycin C (MMC) in patients with medically uncontrolled open angle glaucoma.Phase:
N/AAccepts Healthy Volunteers?
NoDetails
Lead Sponsor:
Aeon Astron Europe B.V.Treatments:
Mitomycin
Mitomycins
Criteria
Inclusion Criteria:- Age 18 years or over
- Uncontrolled open-angle glaucoma
- Subject is willing to sign informed consent
- Subject is able and willing to complete post-operative follow-up requirements
Exclusion Criteria:
- Inflammatory eye diseases
- Angle-closure glaucoma
- Secondary glaucoma with anatomical malformations of the eye
- Subjects having single functional eye
- Previous conjunctival surgery
- Known allergic reactions to ingredients of ologen Collagen Matrix
- Excessive myopia (axial length (AL)> 27 mm or more than -10 diopters)
- Previous vitrectomy eye surgery
- Subjects do not consent to participate